OBJECTIVES This study sought to develop a clinical model that identifies patients with and without high-risk coronary artery disease (CAD).
T he diagnosis and subsequent stratification of patients with suspected coronary artery disease (CAD) are important to management. Traditionally, patients with CAD are categorized according to the presence and absence of high-risk coronary anatomy because those patients with high-risk CAD often derive the greatest mortality benefit with revascularization (1) (2) (3) .
Conversely, a trial of optimal medical therapy may be appropriate for those patients with nonhigh-risk CAD (4) .
The current standard for the anatomic diagnosis of CAD is invasive coronary angiography (ICA); however, ICA is expensive and has associated procedural hazards (5) . Therefore, it would be desirable to identify patients at greatest probability of high-risk CAD who require further investigations and those patients with low probability of high-risk CAD in whom a trial of optimal medical therapy may be appropriate. Current clinical models estimate a patient's pre-test probability for obstructive CAD, but they do not accurately predict the presence or absence of high-risk CAD (left main coronary artery diameter stenosis $50%, 3-vessel disease [diameter stenosis $70%] or 2-vessel disease involving the proximal left anterior descending artery). Previous models have defined significant CAD as $1 vessel with a $50% or $75% lesion (6) (7) (8) . To our knowledge, no studies have examined models to ascertain likelihood of 'high-risk coronary anatomy'. This is most relevant given recent evidence that optimal medical therapy is a reasonable treatment option in patients with CAD.
Using a large, prospective international registry of patients referred to coronary computed tomographic angiography (CTA) for suspected CAD, this study sought to develop a clinical model to identify the presence and absence of high-risk CAD. were recorded for all patients (6, 10) . A detailed description of the methods has been previously published (9) . Symptoms were analyzed according to the criteria for angina pectoris, in which patients with typical angina exhibited all 3 characteristics (chest pain, onset with exertion, improvement with rest) and atypical angina with any 1 or 2 characteristics (6).
METHODS
Hypertension was defined as a known history of systolic blood pressure >140 mm Hg or treatment with antihypertensive medications. Diabetes mellitus was defined as a previous diagnosis of diabetes or use of oral hypoglycemic drugs or insulin. Dyslipidemia was defined as a known history of dyslipidemia or Predicting High-Risk Coronary Artery Disease -2 0 1 5 : --treatment with lipid-lowering agents. Family history of premature CAD was defined as a first-degree relative with myocardial infarction (<55 years for men, <65 years for women). The CONFIRM registry used standardized definitions of cardiovascular risk factors for data collection to minimize differences among centers (9, 10) . Sites with at least 80% overlap with predefined data dictionary were enrolled into the CONFIRM registry, and they had uniform collection of major categories of patient information including demographics and cardiovascular risk factors (9) .
To compare our model with existing models, the pre-test probability of obstructive CAD ($50% diameter stenosis) was calculated for each patient according to age, sex, and type of chest pain by using the updated Diamond-Forrester model (11) .
CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY.
Coronary CTA image acquisition and interpretation, as previously described, were performed according to clinical routine at each participating center using single-or dual-source 64-slice CT scanners (9) .
Coronary artery diameter stenosis was graded using a 4-point score (normal or mild, <50%; moderate, 50% to 69%; or severe, $70%) (12) . Patients were further categorized according to the presence and absence of high-risk CAD, defined as left main coronary artery stenosis ($50%), 3-vessel disease ($70%), or 2-vessel disease ($70%) involving the proximal left anterior descending artery (13, 14) .
Previous study has shown that coronary CTA is a highly specific and sensitive method for detecting high-risk anatomy compared with ICA (sensitivity, 100%; specificity, 95%) (15 Table 2) . Interaction between sex and other variables was examined and was found to be insignificant. Points for each variable were assigned based on its regression coefficient to generate a scoring system ( Table 3) . Using the score from À1 to 25, the predictive probability of high-risk CAD ranged from 0.1% (95% CI: 0.1 to 0.1) to 51.1% (95% CI: 45.6 to 56.6). The diagnostic value for each threshold of highrisk CAD score was calculated ( (Figure 3) . The accuracy of the score and the Predicting High-Risk Coronary Artery Disease -2 0 1 5 : --proportion of patients classified into each probability category were similar to those of the derivation group ( Table 5 ). The calibration of the score was also similar in both derivation and validation groups (Figure 2) .
DISCUSSION
This study derived a scoring system to predict highrisk CAD in patients with suspected CAD, and it includes variables that can be easily obtained from a patient's history. These variables are similar to other clinical models used to predict obstructive CAD (e.g., Morise, Duke, and Diamond-Forrester scores), but our current variables were developed in a diverse population from multiple centers, thereby validating the model's applicability (6) (7) (8) .
This model appears to be most useful in identifying those patients with the greatest likelihood of having "high-risk coronary anatomy," thereby identifying a group that could benefit most from ICA with or without fractional flow reserve measurements. All other symptomatic patients could potentially be diagnosed and stratified using available noninvasive modalities such as coronary CTA, perfusion imaging, or stress echocardiography.
PROBABILITY OF HIGH-RISK CORONARY ARTERY
DISEASE. High-risk CAD is associated with more frequent adverse events, and these patients typically derive the greatest benefit from revascularization (18) (19) (20) (21) (22) (23) . Clinical trials have shown that, compared with medical therapy, coronary artery bypass graft significantly improves survival of patients with highrisk CAD (1, 2, 24) . Therefore, patients with a high probability of high-risk CAD should be considered for definitive anatomic imaging (e.g., invasive angiography) and possible revascularization. Conversely, Values are n (%).
CAD ¼ coronary artery disease; HRA ¼ high-risk anatomy. This study population consists of patients with stable CAD who were referred for coronary CTA, a highly specific and sensitive method for detecting coronary artery stenosis (15) . In fact, a meta-analysis suggests that coronary CTA should be used to rule Predicting High-Risk Coronary Artery Disease -2 0 CAD, and revascularization history (9) . This standardization helps to reduce inconsistencies among protocols and guidelines across sites.
We also recognize that patients with severe symptoms and other high-risk factors are more likely to be referred directly to ICA. Therefore, our study population may be more reflective of patients with stable CAD in which ICA may not be immediately indicated.
Blood results and medications were not included into the risk model. The intention was to create a simple and easily applied model that was built entirely on clinical factors that could be used at every clinical encounter. In addition, medications were excluded from analysis. Because the duration of medication therapy was not captured, some medications may have been recently initiated in response to the suspicion of CAD and may introduce bias into the model.
CONCLUSIONS
We propose a scoring system based on clinical variables that can be used to identify patients at high and low risk of having high-risk CAD. Identification of these populations may detect those who may benefit from a trial of medical therapy and those who may benefit most from an invasive strategy. pre-test probability of having high-risk CAD. This scoring system may detect those who benefit from a trial of medical therapy and those who may benefit most from an invasive strategy.
TRANSLATIONAL OUTLOOK: Additional studies are needed to validate this scoring system further in the stable outpatient population referred for noninvasive testing. 
